Related Experiment Video
Updated: Jul 10, 2026
08:00
A Detailed Protocol for Characterizing the Murine C1498 Cell Line and its Associated Leukemia Mouse Model
Published on: October 14, 2016
Murine models for chronic lymphocytic leukaemia
A M Michie1, R Nakagawa, A M McCaig
1Section of Experimental Haematology, Division of Cancer Sciences and Molecular Pathology, University of Glasgow, 10 Alexandra Parade, Glasgow G31 2ER, U.K. a.michie@udcf.gla.ac.uk
Biochemical Society Transactions
|October 25, 2007
Summary
Mouse models are crucial for understanding chronic lymphocytic leukemia (CLL) and testing new therapies. Recent advances in developing these models offer new insights into CLL triggers and treatments.
Area of Science:
- Hematology
- Immunology
- Oncology
Background:
- Chronic lymphocytic leukemia (CLL) involves malignant B-lymphocytes with a specific phenotype (CD19hiCD5+CD23+IgMlo).
- CLL cells accumulate in peripheral blood and lymphoid organs, arrested in G0/G1 phase, and resist apoptosis.
- Ex vivo apoptosis of CLL cells suggests dependence on microenvironmental survival signals.
Purpose of the Study:
- To review recent advances in the development of mouse models for CLL.
- To highlight the utility of these models in understanding CLL pathogenesis and preclinical therapy testing.
Main Methods:
- Development of murine models that replicate human CLL.
- Utilizing peripheral blood samples from CLL patients for research.
Main Results:
- Murine models provide a deeper understanding of potential CLL triggers.
- These models serve as preclinical in vivo systems for novel therapy evaluation.
Conclusions:
- Mouse models are instrumental in advancing CLL research.
- Recent developments in CLL mouse models are key for future therapeutic strategies.
